|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00010 HANG LUNG GROUP
Nominal 
10.560 -0.020 (-0.189%) | 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Turnover | 10,881,000 | -0.548% | 10,941,000 | 10,919,000 | 9,526,000 | 9,435,000 |
| Cost of Sales | (3,087,000) | -5.249% | (3,258,000) | (3,112,000) | (2,646,000) | (2,537,000) |
| Gross Profit | 7,794,000 | 1.445% | 7,683,000 | 7,807,000 | 6,880,000 | 6,898,000 |
| 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | (62,000) | -82.386% | (352,000) | 458,000 | (6,856,000) | 10,620,000 | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 127,000 | -16.993% | 153,000 | (14,000) | (291,000) | 183,000 | |
| Profit / (Loss) before Taxation | 6,574,000 | 3.495% | 6,352,000 | 7,266,000 | (924,000) | 17,978,000 | |
| Taxation | (1,659,000) | 6.551% | (1,557,000) | (2,191,000) | (1,261,000) | (5,403,000) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (2,104,000) | 1.300% | (2,077,000) | (2,486,000) | 644,000 | (5,759,000) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 2,811,000 | 3.422% | 2,718,000 | 2,589,000 | (1,541,000) | 6,816,000 | |
| 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Net Finance Costs / (Income) | 618,000 | 33.190% | 464,000 | 427,000 | 152,000 | (16,000) |
| Depreciation & Amortisation | 88,000 | 12.821% | 78,000 | 62,000 | 48,000 | 50,000 |
| Directors' Emoluments | 119,600 | -7.359% | 129,100 | 125,000 | 110,200 | 110,300 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | 206.000 | 3.000% | 200.000 | 190.000 | -113.000 | 501.000 |
| DPS (cts) | 86.000 | -- | 86.000 | 86.000 | 82.000 | 108.000 |
| Dividend Payout Ratio (%) | 41.748% | -- | 43.000% | 45.263% | -- | 21.557% |
| Cash flow per share ($) | 2.954 | -- | 3.263 | 2.235 | 2.762 | 4.185 |
| NBV per share ($) | 69.300 | -- | 68.168 | 70.388 | 67.644 | 67.048 |
| Remarks: | Real time quote last updated: 30/12/2024 17:06 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 888,000 |
| %Change | -47.206% |
| EPS / (LPS) | HKD 0.650 |
| NBV Per Share ($) | HKD 70.379 |